Citadel Advisors’s Cue Health Inc. Common Stock HLTH Stock Holding History

Citadel Advisors’s Portfolio HLTH Stock Details HLTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,472	Closed	-$1.48K	–	15511
2023 Q3	$1.98K	Buy	+4,472	New	+$2.04K	﹤0.01%	13777
2023 Q1	–	Sell	-32	Closed	-$70	–	15758
2022 Q4	$66	Buy	+32	New	+$101	﹤0.01%	14776
2021 Q4	–	Sell	-79,406	Closed	-$873K	–	15018
2021 Q3	$938K	Buy	+79,406	New	+$1.25M	﹤0.01%	8317

Other funds holding HLTH

Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return

Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

JPC

Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors's HLTH Position: Q4 2023 in Review

Citadel Advisors sold out of Cue Health Inc. Common Stock (HLTH) in Q4 2023, closing a stake of 4,472 shares — an estimated $1.48K sold.

Citadel Advisors first reported a position in HLTH in Q3 2021 and held it in 3 quarters. The position peaked at $938K in Q3 2021. 63 funds tracked by Wall St. Rank hold HLTH as of Q4 2023.

Citadel Advisors reported no remaining Cue Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Citadel Advisors sold 4,472 Cue Health Inc. Common Stock shares in Q4 2023, an estimated $1.48K.
Citadel Advisors first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Citadel Advisors's Cue Health Inc. Common Stock position peaked at $938K in Q3 2021.
63 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.